Advances in the genetics of anti-glomerular basement membrane disease

American Journal of Nephrology

Volumn 32, Issue 5, 2010, Pages 482-490

  Zhou, Xu Jie ^a   Lv, Ji Cheng ^a   Zhao, Ming Hui ^a   Zhang, Hong ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Anti glomerular basement membrane disease; FCGR; HLA DRB1*1501; KLK

Indexed keywords

COLLAGEN TYPE 4; COLLAGEN TYPE 4 A3; COMPLEMENT; EPITOPE; FC RECEPTOR; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR15 ANTIGEN; HLA DR4 ANTIGEN; INTERLEUKIN 17; KALLIKREIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ANTIGLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; COPY NUMBER VARIATION; ENVIRONMENT; EPIGENETICS; GENE DELETION; GENE DOSAGE; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMORAL IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; QUANTITATIVE TRAIT LOCUS; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIGENS; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY, CELLULAR; KALLIKREINS; MAJOR HISTOCOMPATIBILITY COMPLEX; RECEPTORS, IGG; T-LYMPHOCYTES;

EID: 77957988552     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321324     Document Type: Review

References (63)

1. Chen M, Cui Z, Zhao MH: ANCA-associated vasculitis and anti-GBM disease: the experience in China. Nephrol Dial Transplant 2010;25:2062-2065.
2. Pusey CD: Anti-glomerular basement membrane disease. Kidney Int 2003;64:1535-1550.
3. Lin W, Chen M, Cui Z, Zhao MH: The immunopathological spectrum of crescentic glomerulonephritis: a survey of 106 patients in a single Chinese center. Nephron Clin Pract 2010;116: c65-c74.
4. Knoll G, Rabin E, Burns BF: Antiglomerular basement membrane antibody-mediated nephritis with normal pulmonary and renal function. A case report and review of the literature. Am J Nephrol 1993;13:494-496.
5. Kluth DC, Rees AJ: Anti-glomerular basement membrane disease. J Am Soc Nephrol 1999;10:2446-2453.
6. Ooi JD, Holdsworth SR, Kitching AR: Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. J Autoimmun 2008;31:295-300.
7. Salama AD, Levy JB, Lightstone L, Pusey CD: Goodpasture's disease. Lancet 2001;358:917-920.
8. Turner AN: Goodpasture's disease. Nephrol Dial Transplant 2001;16(suppl 6):52-54.
9. Borza DB, Neilson EG, Hudson BG: Pathogenesis of Goodpasture syndrome: a molecu lar perspective. Semin Nephrol 2003;23:522-531.
10. Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG: Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010;363:343-354.
11. Yang R, Cui Z, Zhao J, Zhao MH: The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clin Immunol 2009;133:245-250.
12. Phelps RG, Rees AJ: The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 1999;56:1638-1653.
13. Cui Z, Zhao MH, Singh AK, Wang HY: Antiglomerular basement membrane disease with normal renal function. Kidney Int 2007;72:1403-1408.
14. Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, Hudson BG: The Goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3 (IV) collagen chain. J Biol Chem 2000;275:6030-6037.
15. Persson U, Hertz JM, Carlsson M, Hellmark T, Juncker I, Wieslander J, Segelmark M: Patients with Goodpasture's disease have two normal COL4A3 alleles encoding the NC1 domain of the type IV collagen alpha 3 chain. Nephrol Dial Transplant 2004;19:2030-2035.
16. Reynolds J, Cook PR, Ryan JJ, Norsworthy PJ, Glazier AM, Duda MA, Evans DJ, Aitman TJ, Pusey CD: Segregation of experimental autoimmune glomerulonephritis as a complex genetic trait and exclusion of COL4A3 as a candidate gene. Exp Nephrol 2002;10:402-407.
17. Vanacore RM, Ham AJ, Cartailler JP, Sundaramoorthy M, Todd P, Pedchenko V, Sado Y, Borza DB, Hudson BG: A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. J Biol Chem 2008;283:22737-22748.
18. Vanacore RM, Ham AJ, Voehler M, Sanders CR, Conrads TP, Veenstra TD, Sharpless KB, Dawson PE, Hudson BG: A sulfilimine bond identified in collagen I V. Science 2009;325:1230-1234.
19. Salant DJ: Goodpasture's disease - new secrets revealed. N Engl J Med 2010;363:388-391.
20. Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD: Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008;4: e1000024.
21. Miretti MM, Walsh EC, Ke X, Delgado M, Griffiths M, Hunt S, Morrison J, Whittaker P, Lander ES, Cardon LR, Bentley DR, Rioux JD, Beck S, Deloukas P: A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 2005;76:634-646.
22. * 1501 is regulated by vitamin D. PLoS Genet 2009;5: e1000369.
23. Phelps RG, Jones V, Turner AN, Rees AJ: Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunol 2000;12:1135-1143.
24. Cui Z, Zhao MH: Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin Immunol 2005;116:77-82. (Pubitemid 40733585)
25. Cui Z, Wang HY, Zhao MH: Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 2006;69:894-899.
26. Zhao J, Cui Z, Yang R, Jia XY, Zhang Y, Zhao MH: Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. Kidney Int 2009;76:1108-1115.
27. Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, Wang HY: Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 2009;24:1838-1844.
28. Meyers KE, Christensen M, Madaio MP: Modeling of human anti-GBM antibodyalpha3 (IV) NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3 (IV) NC1. Am J Nephrol 2009;30:474-480.
29. Clynes R, Dumitru C, Ravetch JV: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998;279:1052-1054.
30. Takai T: Roles of Fc receptors in autoimmunit y. Nat Rev Immunol 2002;2:580-592.
31. Nimmerjahn F, Ravetch JV: Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008;8:34-47.
32. Smith KG, Clatworthy MR: FcgammarIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 2010;10:328-343.
33. Nakamura A, Yuasa T, Ujike A, Ono M, Nukiwa T, Ravetch JV, Takai T: Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 2000;191:899-906.
34. Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV: Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 2006;203:789-797.
35. Tsuboi N, Asano K, Lauterbach M, Mayadas TN: Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 2008;28:833-846.
36. Zhou XJ, Lv JC, Yu L, Cui Z, Zhao J, Yang R, Han J, Hou P, Zhao MH, Zhang H: FCGR2b gene polymorphism rather than FCGR2A, FCGR3A and FCGR3B is associated with anti-GBM disease in Chinese. Nephrol Dial Transplant 2010;25:97-101.
37. Zhou XJ, Lv JC, Bu DF, Yu L, Yang YR, Zhao J, Cui Z, Yang R, Zhao MH, Zhang H: Copy number variation of FCGR3A rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease. Int Immunol 2010;22:45-51.
38. Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, MacAry PA, Rankin A, Lehner PJ, Ouwehand WH, Allen JM, Watkins NA, Smith KG: Loss of function of a lupusassociated FcgammarIIB polymorphism through exclusion from lipid rafts. Nat Med 2005;11:1056-1058.
39. Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E, de Haas M, de Boer M, Roos D, Kuijpers TW: Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 2009;30: E640-E650.
40. Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, McGovern NN, Condliffe AM, Chilvers ER, Adu D, Jolly EC, Watts R, Lau YL, Morgan AW, Nash G, Smith KG: Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008;205:1573-1582.
41. Lv J, Yang Y, Zhou X, Yu L, Li R, Hou P, Zhang H: FCGR3B copy number variation is not associated with lupus nephritis in a Chinese population. Lupus 2010;19:158-161.
42. Yang H, Zhou Q, Chen D, Jiang H, Mao Y, Chen J: The single nucleotide polymorphisms gene but not the copy number variation of FCGR3B is associated with lupus nephritis in Chinese people. Lupus 2010;19:662-664.
43. Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, Scott JA, Urban BC, Peshu N, Dunstan SJ, Hien TT, Phu NH, Padyukov L, Gunnarsson I, Svenungsson E, Savage CO, Watts RA, Lyons PA, Clayton DG, Smith KG: Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet 2010;19:3282-3294.
44. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavare S, Deloukas P, Hurles ME, Dermitzakis ET: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007;315:848-853.
45. Chen M, Daha MR, Kallenberg CG: The complement system in systemic autoimmune disease. J Autoimmun 2010;34: J276-J286.
46. Sylvestre D, Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV: Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med 1996;184:2385-2392.
47. Sheerin NS, Abe K, Risley P, Sacks SH: Accumulation of immune complexes in glomerular disease is independent of locally synthesized C3. J Am Soc Nephrol 2006;17:686-696.
48. Robson MG, Cook HT, Botto M, Taylor PR, Busso N, Salvi R, Pusey CD, Walport MJ, Davies KA: Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol 2001;166:6820-6828.
49. Sheerin NS, Springall T, Carroll MC, Hartley B, Sacks SH: Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3-and C4-deficient mice. Clin Exp Immunol 1997;110:403-409.
50. Otten MA, Groeneveld TW, Flierman R, Rastaldi MP, Trouw LA, Faber-Krol MC, Visser A, Essers MC, Claassens J, Verbeek JS, van Kooten C, Roos A, Daha MR: Both complement and IgG Fcreceptors are required for development of attenuated antiglomerular basement membrane nephritis in mice. J Immunol 2009;183:3980-3988.
51. Wu J, Hicks J, Borillo J, Glass WN, Lou YH: CD4 (+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 2002;109:517-524.
52. Reynolds J, Norgan VA, Bhambra U, Smith J, Cook HT, Pusey CD: Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2002;13:359-369.
53. Ooi JD, Phoon RK, Holdsworth SR, Kitching AR: IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J Am Soc Nephrol 2009;20:980-989.
54. Mesnard L, Keller AC, Michel ML, Vandermeersch S, Rafat C, Letavernier E, Tillet Y, Rondeau E, Leite-de-Moraes MC: Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis. J Am Soc Nephrol 2009;20:1282-1292.
55. Xie C, Rahman ZS, Xie S, Zhu J, Du Y, Qin X, Zhou H, Zhou XJ, Mohan C: Strain distribution pattern of immune nephritis - a follow-up study. Int Immunol 2008;20:719-728.
56. Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sanchez E, Kelly JA, Li L, Liu Y, Zhou J, Yan M, Ye Q, Liu S, Xie C, Zhou XJ, Chung SA, Pons-Estel B, Witte T, de Ramon E, Bae SC, Barizzone N, Sebastiani GD, Merrill JT, Gregersen PK, Gilkeson GG, Kimberly R P, Vyse TJ, Kim I, D'Alfonso S, Martin J, Harley JB, Criswell LA, Wakeland EK, Alarcon-Riquelme ME, Mohan C: Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest 2009;119:911-923.
57. Kakoki M, Smithies O: The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int 2009;75:1019-1030.
58. Zhou XJ, Lv JC, Zhao MH, Zhang H: Klk1 gene polymorphisms are not associated with lupus nephritis in a Chinese Han population. J Rheumatol 2010;37:1359-1360.
59. Hirschhorn JN: Genomewide association studies - illuminating biologic pathways. N Engl J Med 2009;360:1699-1701.
60. Zenewicz LA, Abraham C, Flavell RA, Cho JH: Unraveling the genetics of autoimmunity. Cell 2010;140:791-797.
61. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH: Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010;11:446-450.
62. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M: Mapping complex disease traits with global gene expression. Nat Rev Genet 2009;10:184-194.
63. Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J, Charles P, Ding B, Alfredsson L, Padyukov L, Symmons DP, Venables PJ, Klareskog L, Lundberg K: Specific interaction between genotype, smoking and autoimmunity to citrullinated alphaenolase in the etiology of rheumatoid arthritis. Nat Genet 2009;41:1319-1324.